CXCL12 and diabetes mellitus: CCR2/CCR5 inhibitors could reduce the content of stromal cell‐derived factor‐1 (SDF‐1), intercellular cell adhesion molecule‐1 (ICAM‐1) and retinal vascular permeability in DM animals.101